Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.100

+0.020 (1.85%)

At close: Mar 20, 2026, 4:00 PM EDT

1.130

+0.030 (2.73%)

After-hours: Mar 20, 2026, 7:29 PM EDT

Fate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	46.63	36.06	41.87	61.33	133.58
Short-Term Investments	157.03	243.01	273.31	374.89	482.33
Cash & Short-Term Investments	203.66	279.07	315.18	436.23	615.91
Cash Growth	-27.02%	-11.46%	-27.75%	-29.17%	27.54%
Accounts Receivable	0.92	3.54	1.83	38.48	8.68
Other Current Assets	4.13	9.3	14.54	27.37	8.83
Total Current Assets	208.7	291.91	331.54	502.07	633.41
Net Property, Plant & Equipment	98.53	110.89	158.51	176.09	162.25
Long-Term Investments	1.47	27.66	0.98	4.94	100.66
Other Long-Term Assets	10.23	10.24	15.19	22.46	25.13
Total Assets	318.94	440.69	506.22	705.56	921.46
Accounts Payable	2.66	9.37	4.72	8.27	8.61
Accrued Expenses	20.02	21.35	27.51	53.93	42.41
Current Portion of Leases	4.56	7.42	6.18	5.63	5.58
Unearned Revenue	0.38	0.39	0.69	42.23	48.61
Other Current Liabilities	8.45	-	-	4	3.2
Total Current Liabilities	36.07	38.52	39.09	114.05	81.28
Long-Term Leases	73.29	77.85	97.36	103.71	109.24
Other Long-Term Liabilities	2.4	5.6	1.35	3.86	24.97
Total Long-Term Liabilities	75.68	83.45	98.71	107.57	134.21
Total Liabilities	111.75	121.97	137.8	221.62	215.49
Preferred Stock	0	0	0	0	0
Common Stock	0.12	0.11	0.1	0.1	0.1
Additional Paid-in Capital	1,741	1,716	1,580	1,536	1,449
Accumulated Other Comprehensive Income	0.12	0.27	0.02	-1.85	-0.76
Retained Earnings	-1,534	-1,398	-1,212	-1,051	-769.08
Shareholders' Equity	207.18	318.73	368.42	483.94	678.84
Total Liabilities & Equity	318.94	440.69	506.22	705.56	921.46
Total Debt	77.85	85.27	103.54	109.34	114.82
Net Cash (Debt)	125.81	193.8	211.64	326.89	501.09
Net Cash Growth	-35.09%	-8.43%	-35.26%	-34.77%	29.95%
Net Cash Per Share	1.06	1.71	-	3.38	5.29
Book Value	207.18	318.73	368.42	483.94	678.84
Book Value Per Share	1.74	2.80	-	5.00	7.16
Tangible Book Value	207.18	318.73	368.42	483.94	678.84
Tangible Book Value Per Share	1.74	2.80	-	5.00	7.16

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q